business
Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation
Key takeaways
- SYK trades at roughly 22x forward earnings versus ISRG's premium 39x, as da Vinci procedure growth guidance steps down from 18% to roughly 15%.
- Stryker's Mako franchise, Inari-boosted vascular arm, and free cash flow jumping 227% to $415 million make it the stronger structural compounder pick this quarter.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Intuitive Surgical didn't make the cut.
Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation Alex Sirois Wed, July 1, 2026 at 10:14 PM GMT+7 3 min read ISRG SYK NVDA Quick Read A March cyberattack pushed SYK below estimates, while ISRG crushed forecasts with 23% revenue growth and EPS of $2.50 against a $2.11 consensus.
SYK trades at roughly 22x forward earnings versus ISRG's premium 39x, as da Vinci procedure growth guidance steps down from 18% to roughly 15%.
Stryker's Mako franchise, Inari-boosted vascular arm, and free cash flow jumping 227% to $415 million make it the stronger structural compounder pick this quarter.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop